174 related articles for article (PubMed ID: 21630125)
1. High expression of Y-box-binding protein-1 is associated with poor survival in resectable esophageal squamous cell carcinoma.
Li Y; Wen ZS; Yang HX; Luo RZ; Zhang Y; Zhang MF; Wang X; Jia WH
Ann Surg Oncol; 2011 Nov; 18(12):3370-6. PubMed ID: 21630125
[TBL] [Abstract][Full Text] [Related]
2. Prognostic relevance of Id-1 expression in patients with resectable esophageal squamous cell carcinoma.
Luo KJ; Wen J; Xie X; Fu JH; Luo RZ; Wu QL; Hu Y
Ann Thorac Surg; 2012 May; 93(5):1682-8. PubMed ID: 22480390
[TBL] [Abstract][Full Text] [Related]
3. Elevated expression of Rad51 is correlated with decreased survival in resectable esophageal squamous cell carcinoma.
Li Y; Yu H; Luo RZ; Zhang Y; Zhang MF; Wang X; Jia WH
J Surg Oncol; 2011 Nov; 104(6):617-22. PubMed ID: 21744352
[TBL] [Abstract][Full Text] [Related]
4. Tyrosine-protein phosphatase nonreceptor type 12 is a novel prognostic biomarker for esophageal squamous cell carcinoma.
Cao X; Li Y; Luo RZ; He LR; Yang J; Zeng MS; Wen ZS
Ann Thorac Surg; 2012 May; 93(5):1674-80. PubMed ID: 22429674
[TBL] [Abstract][Full Text] [Related]
5. MiR-142-3p as a potential prognostic biomarker for esophageal squamous cell carcinoma.
Lin RJ; Xiao DW; Liao LD; Chen T; Xie ZF; Huang WZ; Wang WS; Jiang TF; Wu BL; Li EM; Xu LY
J Surg Oncol; 2012 Feb; 105(2):175-82. PubMed ID: 21882196
[TBL] [Abstract][Full Text] [Related]
6. Survival factors in patients with recurrence after curative resection of esophageal squamous cell carcinomas.
Miyata H; Yamasaki M; Kurokawa Y; Takiguchi S; Nakajima K; Fujiwara Y; Konishi K; Mori M; Doki Y
Ann Surg Oncol; 2011 Nov; 18(12):3353-61. PubMed ID: 21537861
[TBL] [Abstract][Full Text] [Related]
7. Endoscopic tumor length is an independent prognostic factor in esophageal squamous cell carcinoma.
Wang BY; Liu CY; Lin CH; Hsu PK; Hsu WH; Wu YC; Cheng CY
Ann Surg Oncol; 2012 Jul; 19(7):2149-58. PubMed ID: 22407313
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of raf kinase inhibitor protein in esophageal squamous cell carcinoma.
Gao C; Pang L; Ren C; Ma T
Pathol Oncol Res; 2012 Apr; 18(2):471-7. PubMed ID: 22102006
[TBL] [Abstract][Full Text] [Related]
9. [Survival analysis of patients with stage II squamous cell carcinoma of the thoracic esophagus after esophagectomy].
Zhang DK; Su XD; Lin P
Ai Zheng; 2008 Feb; 27(2):113-8. PubMed ID: 18279605
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of stromal caveolin-1 expression in esophageal squamous cell carcinoma: a potent predictor of lymph node metastases, early tumor recurrence, and poor prognosis.
Jia Y; Wang N; Wang J; Tian H; Ma W; Wang K; Tan B; Zhang G; Yang S; Bai B; Cheng Y
Ann Surg Oncol; 2014 Jan; 21(1):329-36. PubMed ID: 23982252
[TBL] [Abstract][Full Text] [Related]
11. STMN-1 gene: a predictor of survival in stage iia esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy?
Akhtar J; Wang Z; Yu C; Zhang ZP; Bi MM
Ann Surg Oncol; 2014 Jan; 21(1):315-21. PubMed ID: 23975322
[TBL] [Abstract][Full Text] [Related]
12. Prognostic implication of ezrin expression in esophageal squamous cell carcinoma.
Xie JJ; Xu LY; Wu ZY; Zhao Q; Xu XE; Wu JY; Huang Q; Li EM
J Surg Oncol; 2011 Oct; 104(5):538-43. PubMed ID: 21416469
[TBL] [Abstract][Full Text] [Related]
13. High expression of p300 has an unfavorable impact on survival in resectable esophageal squamous cell carcinoma.
Li Y; Yang HX; Luo RZ; Zhang Y; Li M; Wang X; Jia WH
Ann Thorac Surg; 2011 May; 91(5):1531-8. PubMed ID: 21524463
[TBL] [Abstract][Full Text] [Related]
14. Significance of lymph node capsular invasion in esophageal squamous cell carcinoma.
Sakai M; Suzuki S; Sano A; Tanaka N; Inose T; Sohda M; Nakajima M; Miyazaki T; Kuwano H
Ann Surg Oncol; 2012 Jun; 19(6):1911-7. PubMed ID: 22290569
[TBL] [Abstract][Full Text] [Related]
15. Cytokeratin 7 is a predictive marker for survival in patients with esophageal squamous cell carcinoma.
Oue N; Noguchi T; Anami K; Kitano S; Sakamoto N; Sentani K; Uraoka N; Aoyagi K; Yoshida T; Sasaki H; Yasui W
Ann Surg Oncol; 2012 Jun; 19(6):1902-10. PubMed ID: 22203179
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinases expression correlates with survival in patients with esophageal squamous cell carcinoma.
Gu ZD; Li JY; Li M; Gu J; Shi XT; Ke Y; Chen KN
Am J Gastroenterol; 2005 Aug; 100(8):1835-43. PubMed ID: 16086722
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of nm23-H1 expression in esophageal squamous cell carcinoma.
Wang LS; Chow KC; Lien YC; Kuo KT; Li WY
Eur J Cardiothorac Surg; 2004 Aug; 26(2):419-24. PubMed ID: 15296908
[TBL] [Abstract][Full Text] [Related]
18. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
Wang KL; Wu TT; Choi IS; Wang H; Resetkova E; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Albarracin CT
Cancer; 2007 Feb; 109(4):658-67. PubMed ID: 17211865
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic and prognostic value of 18F-FDG PET/CT for patients with suspected recurrence from squamous cell carcinoma of the esophagus.
Guo H; Zhu H; Xi Y; Zhang B; Li L; Huang Y; Zhang J; Fu Z; Yang G; Yuan S; Yu J
J Nucl Med; 2007 Aug; 48(8):1251-8. PubMed ID: 17631554
[TBL] [Abstract][Full Text] [Related]
20. Reduced axin protein expression is associated with a poor prognosis in patients with squamous cell carcinoma of esophagus.
Li AF; Hsu PK; Tzao C; Wang YC; Hung IC; Huang MH; Hsu HS
Ann Surg Oncol; 2009 Sep; 16(9):2486-93. PubMed ID: 19582507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]